The Fortune 500 pharma giant will sequence the exomes of 10 million people, with the goal of developing new therapies and ...

If you suffered losses exceeding $100,000 in Regeneron between November 2, 2023 and October 30, 2024 and would like to discuss your legal rights, call Faruqi & Faruqi partner Josh Wilson directly at ...

SAN DIEGO, CA / ACCESSWIRE / January 15, 2025 / Robbins LLP reminds investors that a class action was filed on behalf of all ...

After Regeneron Chief Scientific Officer George Yancopoulos, M.D., Ph.D., spent more than 25 minutes waxing about the company ...

Regeneron Pharmaceuticals Inc. closed 42.77% short of its 52-week high of $1,211.20, which the company achieved on August ...

Regeneron Pharmaceuticals Inc (REGN) stock saw a decline, ending the day at $681.58 which represents a decrease of $-11.65 or -1.68% from the prior close of $693.23. The stock opened at $705.34 and ...

Medical data research company Truveta said on Monday that Regeneron Pharmaceuticals, Illumina and 17 U.S. health systems will ...

Regeneron Pharmaceuticals Inc.'s executives and board members overstated its key eye treatment’s average selling price, ...

Regeneron Pharmaceuticals Inc. closed 41.92% below its 52-week high of $1,211.20, which the company reached on August 27th.

North Shore High School students Kaitlin Ho and Eli Weseley-Jones were named among the top 300 scholars in the 2025 Regeneron ...

Regeneron Pharmaceuticals, Inc. and executives overstated the average selling price for the drugmaker’s key eye treatment, ...

The positive trial results could help Regeneron cushion the blow of its disappointing fourth-quarter sales for Eylea, which ...